Core Insights - Becton Dickinson (BDX) reported quarterly earnings of $3.96 per share, exceeding the Zacks Consensus Estimate of $3.92 per share, and showing an increase from $3.81 per share a year ago, representing an earnings surprise of +1.02% [1] - The company achieved revenues of $5.89 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.04% and up from $5.44 billion year-over-year [2] - Becton Dickinson has outperformed consensus EPS estimates in all four quarters over the past year, while it has topped revenue estimates three times in the same period [2] Earnings Outlook - The future performance of Becton Dickinson's stock will largely depend on management's commentary during the earnings call and the sustainability of its immediate price movement based on the latest earnings numbers and future expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $3.25 on revenues of $5.39 billion, and for the current fiscal year, it is $14.79 on revenues of $22.77 billion [7] Industry Context - The Medical - Dental Supplies industry, to which Becton Dickinson belongs, is currently ranked in the top 17% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - The correlation between near-term stock movements and earnings estimate revisions suggests that tracking these revisions can provide insights into potential stock performance [5]
Becton Dickinson (BDX) Tops Q4 Earnings and Revenue Estimates